List of works - Grégory Verdeil

29th Annual meeting of the Society for Immunotherapy of Cancer (SITC).

scientific article published on 19 May 2015

Activated STAT5 promotes long-lived cytotoxic CD8+ T cells that induce regression of autochthonous melanoma

scientific article published on 07 November 2011

Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling

scientific article published on 4 September 2013

Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy

scholarly article

CD8 T Cell Help for Innate Antitumor Immunity

scientific article published on 01 November 2007

Contribution of TCR signaling strength to CD8+ T cell peripheral tolerance mechanisms

scientific article

Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca2+ signalling and granule mobilization

scientific article published on 07 October 2016

Distinct thresholds for CD8 T cell activation lead to functional heterogeneity: CD8 T cell priming can occur independently of cell division.

scientific article published in March 2003

Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice

scientific article

From T cell "exhaustion" to anti-cancer immunity.

scientific article published on 27 June 2015

Gene profiling approach to establish the molecular bases for partial versus full activation of naïve CD8 T lymphocytes

scientific article published in December 2002

Immunosuppression in inflammatory melanoma: can it be resisted by adoptively transferred T cells?

scientific article published on 27 December 2012

Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patients

scientific article published on 02 February 2021

Inhibitory Receptors Beyond T Cell Exhaustion.

scientific article published on 26 June 2015

LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures

scientific article published on 12 March 2020

MAF drives CD8(+) T-cell exhaustion

scientific article published on 31 August 2015

Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.

scientific article

Murine CD8 T-cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density

scientific article published on 10 December 2019

Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells.

scientific article published in September 2017

Regulatory circuits of T cell function in cancer

scientific article published on 16 August 2016

Temporal cross-talk between TCR and STAT signals for CD8 T cell effector differentiation.

scientific article published on December 2006

The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells

scientific article

Unleashing antitumor T-cell activation without ensuing autoimmunity: the case for A20-deletion in adoptive CD8(+) T-cell therapy

scientific article published in October 2014

Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients

scientific article published on 12 December 2016

List of works by Grégory Verdeil

29th Annual meeting of the Society for Immunotherapy of Cancer (SITC).

Activated STAT5 promotes long-lived cytotoxic CD8+ T cells that induce regression of autochthonous melanoma

Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling

Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy

CD8 T Cell Help for Innate Antitumor Immunity

Contribution of TCR signaling strength to CD8+ T cell peripheral tolerance mechanisms

Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca2+ signalling and granule mobilization

Distinct thresholds for CD8 T cell activation lead to functional heterogeneity: CD8 T cell priming can occur independently of cell division.

Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice

From T cell "exhaustion" to anti-cancer immunity.

Gene profiling approach to establish the molecular bases for partial versus full activation of naïve CD8 T lymphocytes

Immunosuppression in inflammatory melanoma: can it be resisted by adoptively transferred T cells?

Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patients

Inhibitory Receptors Beyond T Cell Exhaustion.

LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures

MAF drives CD8(+) T-cell exhaustion

Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.

Murine CD8 T-cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density

Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells.

Regulatory circuits of T cell function in cancer

Temporal cross-talk between TCR and STAT signals for CD8 T cell effector differentiation.

The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells

Unleashing antitumor T-cell activation without ensuing autoimmunity: the case for A20-deletion in adoptive CD8(+) T-cell therapy

Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients